Kangsheng Tu
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 2%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 13
- RNA modifications and cancer 13
- Ubiquitin and proteasome pathways 10
-
- Cancer-related molecular mechanisms research 26
- MicroRNA in disease regulation 14
- Cancer, Hypoxia, and Metabolism 12
- Co-authors
- Qingguang Liu (31 shared papers)Yufeng Wang (26 shared papers)Zhikui Liu (29 shared papers)Qiuran Xu (31 shared papers)Wei Yang (16 shared papers)Xin Zheng (18 shared papers)Changwei Dou (19 shared papers)Mingzhen Zhang (18 shared papers)
- Journals
- Cell Death and Disease (7 papers)Molecular Cancer (6 papers)Journal of Experimental & Clinical Cancer Research (5 papers)Biomedicine & Pharmacotherapy (4 papers)Oncology Reports (4 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Kangsheng Tu
107 papers receiving 5.6k citations
Kangsheng Tu's Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 2.1k
- Molecular Biology 3.0k
- Hepatology 287
- Oncology 597
- Cell Biology 378
Countries citing papers authored by Kangsheng Tu
This map shows the geographic impact of Kangsheng Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangsheng Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangsheng Tu more than expected).
Fields of papers citing papers by Kangsheng Tu
This network shows the impact of papers produced by Kangsheng Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangsheng Tu. The network helps show where Kangsheng Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Kangsheng Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Deciphering the catalytic mechanism of superoxide dismutase activity of carbon dot nanozyme Hit paper breakdown → | 2023 | 475 |
| 2 | 2019 | 312 | |
| 3 | Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy Hit paper breakdown → | 2022 | 212 |
| 4 | 2017 | 204 | |
| 5 | 2017 | 197 | |
| 6 | 2018 | 182 | |
| 7 | Integrating Pt nanoparticles with carbon nanodots to achieve robust cascade superoxide dismutase-catalase nanozyme for antioxidant therapy Hit paper breakdown → | 2023 | 168 |
| 8 | 2014 | 152 | |
| 9 | 2017 | 135 | |
| 10 | 2018 | 129 | |
| 11 | 2018 | 113 | |
| 12 | 2014 | 112 | |
| 13 | 2018 | 110 | |
| 14 | 2019 | 110 | |
| 15 | 2015 | 100 | |
| 16 | 2018 | 99 | |
| 17 | 2023 | 97 | |
| 18 | 2016 | 91 | |
| 19 | 2022 | 84 | |
| 20 | 2020 | 79 |
About Kangsheng Tu
Kangsheng Tu is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Biomedical Engineering, having authored 115 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (26 papers), MicroRNA in disease regulation (14 papers), Circular RNAs in diseases (13 papers), RNA modifications and cancer (13 papers), Cancer, Hypoxia, and Metabolism (12 papers), Ubiquitin and proteasome pathways (10 papers), Advanced Nanomaterials in Catalysis (10 papers) and Nanoplatforms for cancer theranostics (10 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (3.0k citations), Hepatology (287 citations), Oncology (597 citations) and Cell Biology (378 citations). Kangsheng Tu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qingguang Liu, Yufeng Wang, Zhikui Liu, Qiuran Xu, Wei Yang, Xin Zheng, Changwei Dou, Mingzhen Zhang, Bowen Yao and Yingmin Yao. Their work appears in journals such as Cell Death and Disease, Molecular Cancer, Journal of Experimental & Clinical Cancer Research, Biomedicine & Pharmacotherapy and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.